Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does warfarin increase the risk of osteoporotic fracture?

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Szulc P et al. (1996) Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study. Bone 118: 487–488

    Article  Google Scholar 

  2. Caraballo PJ et al. (1999) Changes in bone density after exposure to oral anticoagulants: a meta-analysis. Osteoporos Int 9: 441–448

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Richard Eastell.

Ethics declarations

Competing interests

Consultant for Eli Lilly, Procter and Gamble, Organon and Novartis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eastell, R. Does warfarin increase the risk of osteoporotic fracture?. Nat Rev Endocrinol 2, 484–485 (2006). https://doi.org/10.1038/ncpendmet0274

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0274

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing